Max Schumm

Assistant Professor of Surgery @UTSW_Surgery, Endocrine Surgery Fellow @NYULangone, Surgery Resident @UCLAHealth @UCLASurgery,

[UTSW Simmons Cancer Center @utswcancer]

Please join us in welcoming Max Schumm, M.D., to our endocrine surgery team! He sees patients in Ft. Worth & Dallas and specializes in the surgical management of thyroid nodules, thyroid cancer, & adrenal nodules.

Learn more about Dr. Schumm: https://t.co/lDH0Wqz0Sk. @MSchumm90

[Michael Yeh @michaelyehmd]

On this last day of July, I congratulate all of the endocrine surgery fellows, including our very own @1drchao and @MSchumm90. They are heading to @albanymed and @UTSW_Surgery, respectively. Best wishes on the next stage of your journey!
@UCLASurgeryRes @NYUGSOM_SurgRes

[UCLA General Surgery Residency Program @UCLASurgeryRes]

It was so great seeing everyone at #ACSCC2024!! Once a bruin, always a bruin 🧸

[UCLA General Surgery Residency Program @UCLASurgeryRes]

#ChiefResident photo tradition - jump shot on the helipad!!

[UCLA General Surgery Residency Program @UCLASurgeryRes]

We FELL off our seats 🪑with the #ChiefResident #GroundRounds lectures! So much accomplished already - watch out world 🌎for these future surgeons !!

[Rivfka Shenoy, MD, MS @rivfkaMD]

Beginning of the end…. Thanks for an amazing party @paulschmit4
@UCLASurgeryRes

[Camilo Gonzalez-Velazquez, MD. @camilo_gzzv]

🌟 This week's TIRO x MDs session is a must-attend!

We're honored to have Dr. David Toro-Tobon (@DavidToroT) present on "Treatment Aggressiveness for Differentiated Thyroid Cancers Varies Widely and is Influenced by Physician's Attitude and Local Practice Environment." 🦋🔬

Discussion by: Max Schumm (@MSchumm90)

🗓️ Date: Friday 1/19
⏰ Time: 8 am, EST
🔗 Join here: https://t.co/7XbgMFP8BG

🌍 #Thyroid #Cancer #ThyroidHealth @TIRO_expert

[Max Schumm @MSchumm90]

We’re looking forward to this session on the prognostic value of @ThyroSeq and sharing some of our work from @dgsomucla @UCLASurgeryRes @michaelyehmd @MashaLivhitsMD

[American Thyroid Association @AmThyroidAssn]

We are looking forward to the many presentations planned for #ATA2023 Retweet, share or post this image of you are presenting!

@MarinRead4
@mschumm90
@MelissaGLechenr
@end_mad
@MHartleyLab
@gbrenta1
@HuiyingWang7
@inigo_landa
@gbrenta1
@Inigo_landa

[Clinical Thyroidology @clinicalthyroid]

Moving more toward molecular panels like @ThyroSeq to determine prognosis, the latest study by @MSchumm90 @MelissaGLechner @michaelyehmd @MashaLivhitsMD at @UCLAHealth in @JAMAOto

https://t.co/amXxh5XkcM

#endotwitter #onctwitter @TheAAES @AHNSEndo

[Max Schumm @MSchumm90]

Some great artwork too! @AmThyroidAssn @TheAAES

[Max Schumm @MSchumm90]

https://t.co/XUT5pFjUXo
Hot off the press. Check out our @JAMAOto paper to learn more about the next frontier in the thyroid cancer molecular testing domain @michaelyehmd @MashaLivhitsMD @JamesWuMD @MelissaGLechner @diptisajed @UCLASurgeryRes @UCLASurgery @UCLAPath @UCLAHealth

[Max Schumm @MSchumm90]

In this decision-making study, >90% of thyroid specialists would comply with pt preference to deviate from their recommended treatment for low- to intermediate-risk DTC! @JamesWuMD @michaelyehmd @MashaLivhitsMD @AngelaLeung9 @UCLASurgeryRes @gregDsacks @TheAAES @AmThyroidAssn

[JAMA Surgery @JAMASurgery]

Survey study describes the association between patient preference and physician decision-making in thyroid cancer. https://t.co/YIJ2Zl2fLV

[Michael Yeh @michaelyehmd]

@MashaLivhitsMD @JamesWuMD @rivfkaMD @MSchumm90 I had so much fun making this with you!

[Michael Yeh @michaelyehmd]

Oh my, feeling a little anxious about this one… in which we discuss how to grow a clinical program, “soft skills,” and navigating the job market after surgical training. Special thanks @JamesWuMD @rivfkaMD @MashaLivhitsMD @MSchumm90 @UCLASurgeryRes

[Clinical Thyroidology @clinicalthyroid]

Our summary by @DavidToroT @doctorjuanpa on this study by @MSchumm90 @MashaLivhitsMD @AngelaLeung9 @michaelyehmd @JamesWuMD examining how clinicians assess and treat #thyroid cancer risk. @AmThyroidAssn @TheAAES @AAOHNS @AHNSEndo @JofSurgOnc

https://t.co/EQOFBIWCcB

[Max Schumm @MSchumm90]

This study has laid the groundwork for prospective automated surveillance of incidental adrenal nodules to initiate guideline recommended management at our institution @MashaLivhitsMD @JamesWuMD @michaelyehmd @VivekSantMD @UCLAHealth @UCLASurgeryRes

[Steven D Wexner MD, PhD @SWexner]

Automated extraction of incidental adrenal nodules from electronic health records Open access in @SurgJournal https://t.co/129xinKeYf @TheAAES @TheAACE @TheEndoSociety

[James Wu @JamesWuMD]

Our newest pod, challenging thyroid cancer cases with special guest Dr. Kepal Patel from NYU!

Spoiler alert he uses nerve monitoring

@UCLASurgeryRes @TheAAES @michaelyehmd @MashaLivhitsMD @VivekSantMD @rivfkaMD @MSchumm90

[Max Schumm @MSchumm90]

Grateful for the opportunity to present our work and to listen and learn from experts in this amazing field @TheAAES @UCLASurgeryRes

[American Association of Endocrine Surgeons @TheAAES]

#AAES2022

“Automatic Extraction of Incidental Adrenal Nodules from Narrative Radiology Reports in EHRs: A Validation Study” by Dr. Max Schumm @MSchumm90 @JamesWuMD @VivekSantMD @StevenSRaman_MD @MashaLivhitsMD @UCLASurgery

@TheAACE @TheEndoSociety @NADF_President

[James Wu @JamesWuMD]

In this pod:
•4 gland vs MIP
•Nerve monitoring yes vs no
•Age cut-off for parathyroid surgery

Young, hip endocrine surgeons (@MashaLivhitsMD @VivekSantMD @JamesWuMD) vs near-boomer @michaelyehmd

@rivfkaMD @MSchumm90 @UCLASurgeryRes

[Razmik Ghukasyan, M.D., M.B.A. @RGhukasyan]

@MSchumm90 starting off #ASC2022 strong with his research on thyroid cancer management and more patient involvement in the decision making process. @JamesWuMD. @UCLASurgeryRes @dgsomucla @UCLASurgery @UCLAHealth